AdaptHealth Corp. AHCO
At closeNov 3, 2026, 4:21 PM EST
After hours · Nov 3, 4:21 PM ET
- YTD
- -36.95%
- 1 year
- -30.91%
- Market cap
- 854.42M
- Revenue (ttm)
- 3.29B
- Profit margin
- -2.42%
- EPS (ttm)
- -1.82
- Shares out
- 136.05M
- Forward P/E
- 12.22
- YTD return
- -36.95%
- 1-year return
- -30.91%
- Volume
- 7.67M
- Avg volume
- 3.18M
- Open
- 6.24
- Previous close
- 5.91
- Day's range
- 5.65 – 6.40
- 52-week range
- 5.21 – 13.43
- Beta
- 1.45
- Analysts
- Buy
- Price target
- 13.63 (+117.0%)
- Earnings date
- Nov 3, 2026
2Y -3.87 (-38.13%)
Key statistics
- Enterprise value
- 3.34B
- PEG ratio
- 0.00
- Price / sales
- 0.42
- Price / book
- 0.92
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 5.40%
- Free cash flow
- -27.49M
- Total cash
- 47.96M
- Total debt
- 2.00B
- Return on equity
- -4.85%
- Short % of float
- 7.83%
- 50-day average
- 10.55
- 200-day average
- 10.26
Analyst view
Consensus: buy
- Strong buy5
- Buy1
- Hold2
- Sell0
- Strong sell0
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate -0.01.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 30, 2026 | 0.3378 | — | — | — |
| Aug 4, 2026 | Jun 30, 2026 | 0.1688 | 0.06 | -0.11 | -64.45% |
| May 5, 2026 | Apr 10, 2026 | 0.0125 | -0.06 | -0.07 | -580.00% |
| Feb 24, 2026 | Dec 31, 2025 | 0.34 | 0.27 | -0.07 | -20.59% |
| Nov 4, 2025 | Sep 30, 2025 | 0.24 | 0.22 | -0.02 | -8.33% |
| Aug 5, 2025 | Jun 30, 2025 | 0.15 | 0.01 | -0.14 | -93.33% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 6, 2026 | Baird | main | Outperform | Outperform |
| May 11, 2026 | RBC Capital | main | Outperform | Outperform |
| May 6, 2026 | Canaccord Genuity | main | Buy | Buy |
| May 6, 2026 | UBS | main | Buy | Buy |
| Apr 13, 2026 | Truist Securities | main | Buy | Buy |
| Feb 26, 2026 | Leerink Partners | main | Outperform | Outperform |
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Employees
- 10,900
- Website
- adapthealth.com
News
AdaptHealth Corp. (AHCO) Q3 2026 Earnings Call Transcript 
What AdaptHealth (AHCO) Said on Its Q3 Earnings Call 
AdaptHealth Q3 2026 Earnings Call Transcript 
AdaptHealth Raises FY2026 Sales Guidance from $2.850B-$2.890B to $2.880B-$2.900B vs $2.955B Est 
AdaptHealth Q3 Sales $745.648M Miss $746.446M Estimate 
AdaptHealth Corp. Announces Third Quarter 2026 Earnings Release Date and Conference Call 
Analyzing Precipio (NASDAQ:PRPO) and AdaptHealth (NASDAQ:AHCO) - Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9
AdaptHealth To Participate in Upcoming Investor Conferences 
AdaptHealth Corp. Appoints Harriss T. Currie CFO, Effective Sept. 9, Succeeding Jason Clemens
Your note
Sign in to keep a note on AHCO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARNHART TOBY SCOTT | Chief Operating Officer | Stock Award(Grant) | Jan 29, 2026 | 220,654 |
| CASHIN RICHARD M JR | Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 19, 2026 | 0 |
| CLEMENS JASON A | Chief Financial Officer | Stock Award(Grant) | Jan 29, 2026 | 673,481 |
| FOSTER SUZANNE | Chief Executive Officer | Stock Award(Grant) | Jan 29, 2026 | 924,050 |
| LUNDBERG THEODORE B. | Director | Stock Award(Grant) | Jun 23, 2026 | 892,495 |
| OEP VII GP, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 19, 2026 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| OEP CAPITAL ADVISORS, L.P. | 11.99% | 16,312,698 | 0 | Mar 30, 2026 |
| BlackRock Inc | 11.72% | 15,939,953 | 0 | Mar 30, 2026 |
| Vanguard Group Inc | 8.65% | 11,768,599 | 0 | Dec 30, 2025 |
| Deerfield Management Co | 8.44% | 11,477,730 | 0 | Mar 30, 2026 |
| Reinhart Mahoney Capital Management Inc | 7.41% | 10,081,983 | 0 | Mar 30, 2026 |
| SkyKnight Capital, L.P. | 6.31% | 8,580,443 | 0 | Mar 30, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 4.78% | 6,503,832 | 0 | May 28, 2026 |
| Fidelity Value | 3.12% | 4,246,596 | 0 | Apr 29, 2026 |
| Vanguard Total Stock Mkt Idx Inv | 2.36% | 3,206,434 | 0 | Apr 29, 2026 |
| iShares Russell 2000 ETF | 1.80% | 2,445,727 | 0 | May 28, 2026 |
| Vanguard Small Cap Index | 1.72% | 2,345,233 | 0 | Apr 29, 2026 |
| Reinhart Genesis PMV Advisor | 1.30% | 1,762,700 | 0 | Mar 30, 2026 |